Efficacy and Treatment Strategies in Advanced Cancers with Liver Metastasis Receiving Atezolizumab Therapy.

Yin, Wen-Jing; Ma, Si-Cong; Dong, Zhong-Yi; Xu, Meng; Mao, Wu

Yin, Wen-Jing; Ma, Si-Cong; Dong, Zhong-Yi; Xu, Meng; Mao, Wu.

Afiliación

Yin WJ; Department of Oncology, The First Affiliated Hospital of Jinan University, Guangzhou, People's Republic of China.
Ma SC; Department of Radiation Oncology, Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou, People's Republic of China.
Dong ZY; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, People's Republic of China.
Xu M; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, People's Republic of China.
Mao W; Department of Oncology, The First Affiliated Hospital of Jinan University, Guangzhou, People's Republic of China.

Cancer Manag Res ; 13: 4541-4551, 2021.

Article en En | MEDLINE | ID: mdl-34135631

Palabras clave

PD-L1; advantageous; atezolizumab; liver metastasis; pooled analysis

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Cancer Manag Res Año: 2021 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google